‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target

UT Southwestern Medical Center scientists have identified a protein that appears to act as a master control switch for reactive gliosis, a prominent feature of many neurodegenerative diseases that is thought to contribute to their pathology. The researchers’ findings, published in Neuron, could eventually lead to new treatments for Alzheimer’s, Parkinson’s, and Huntington’s diseases and other neurodegenerative conditions.